Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-26T07:40:30.111Z Has data issue: false hasContentIssue false

Protective role of sardine protein (Sardina pilchardus) against high fructose-induced metabolic syndrome rat

Published online by Cambridge University Press:  04 June 2010

Z. Madani
Affiliation:
Laboratoire de Nutrition Clinique et Métabolique, Faculté des Sciences, Université d'Oran Es-Sénia, 31 000 Algeria
D. Ait Yahia
Affiliation:
Laboratoire de Nutrition Clinique et Métabolique, Faculté des Sciences, Université d'Oran Es-Sénia, 31 000 Algeria
F. Boukortt
Affiliation:
Laboratoire de Nutrition Clinique et Métabolique, Faculté des Sciences, Université d'Oran Es-Sénia, 31 000 Algeria
K. Louchami
Affiliation:
Laboratoire d'Hormonologie Expérimentale, Bât GE-CP 626, Route de Lennik 808, B-1070 Bruxelles, Belgique
A. Sener
Affiliation:
Laboratoire d'Hormonologie Expérimentale, Bât GE-CP 626, Route de Lennik 808, B-1070 Bruxelles, Belgique
M. Bouchenak
Affiliation:
Laboratoire de Nutrition Clinique et Métabolique, Faculté des Sciences, Université d'Oran Es-Sénia, 31 000 Algeria
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2009

Feeding rats high fructose diet affects both glucose and lipid metabolism which result in a cluster of metabolic abnormalities such as glucose intolerance, hypertension, dyslipidaemia and reduced insulin action(Reference Cussons, Stukey and Watts1, Reference Faeh, Minehira and Schwarz2).

The aim of the present study was to evaluate the potential influence of sardine protein on biomarkers of oxidative stress and inflammation in high fructose diet-induced metabolic syndrome rat.

Male Wistar rats (n=26) weighing 200±0 g were divided to four groups of six rats each and fed 20% casein (Cas) or sardine protein (SP) with or without 64% fructose (F) for 2 months. Plasma glucose, insulin, lipids, tumour necrosis factor-α and leptin levels were determined. Lipid peroxidation and hydroperoxydes, vitamin (Vit) E and Vit C and antioxidant enzymes activities in liver homogenates were assayed.

The SPF diet diminished by 21% and 51% plasma glucose and glucose intolerance as compared to CasF (P<0.05). Plasma glucose was increased by 39% and 28% in CasF and SPF as compared to Cas and SP, respectively. Plasma insulin levels were reduced by 35% in SPF v. CasF and by 38% in SP v. Cas but were increased by 31% in SPF v. SP. HOMA-IR index was 1.72- and 1.91-fold lower in SPF v. CasF and in SP v. Cas, respectively. Moreover, HOMA index was enhanced by 47% in CasF v. Cas and 64% in SPF v. SP. Plasma cholesterol, triglycerides and free fatty acids levels were significantly lower in SPF and SP rats compared to CasF and Cas. Consumption of SP diet with or without fructose lowered significantly plasma TNF-α values as compared with casein. The high fructose in both the protein diets increased plasma TNF-α by 98% in CasF v. Cas and by 143% in SPF v. SP. Plasma leptin was lower 1.23-fold in SPF than CasF and 2.40-fold in CasF than Cas and 2.28-fold in SPF than SP. Liver hydroperoxides concentrations were enhanced by 18% and 11% in CasF v. Cas groups and in SPF v. SP groups, respectively. Lowered values were noted in liver superoxide dismutase activity in CasF v. Cas (38%) and in SPF v. SP (34%). Glutathione peroxidase activity was 1.6- and 1.42-fold lower in CasF v. Cas and in SPF v. SP, respectively. No significant difference was observed in catalase activity. Feeding SP diet with or without fructose increased significantly liver Vit C. Hepatic Vit C contents were reduced by 39% in CasF v. Cas and 33% in SPF v. SP. Liver Vit E was significantly higher in SP v. Cas. In addition, Vit E levels were 1.53- and 1.63-fold lower in CasF v. Cas and in SPF v. SP rats.

In conclusion, sardine proteins have hypoglycaemic, hypoinsulinaemic and hypolipidaemic effects and improve oxidative and inflammatory stress induced by a high-fructose diet, suggesting that these proteins may have a beneficial action on functional characteristics of pancreatic beta cells, probably by improving insulin and thereby insulin resistance prevention and may contribute to the low risk of coronary heart disease in patients with the metabolic syndrome.

References

1.Cussons, AJ, Stukey, BG & Watts, GF (2007) Curr Diab Rep 7, 6673.CrossRefGoogle Scholar
2.Faeh, D, Minehira, K, Schwarz, JM et al. (2005) Diabetes 54, 19071913.CrossRefGoogle Scholar